Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Adcetris granted conditional approval in Europe for two indications

Nov. 2, 2012

Phase I IPH-2102 trial begins patient recruitment

Oct. 31, 2012

Phase I trial results reported for novel vaccine for glioblastoma

Oct. 30, 2012

Cel-Sci reports interim review results from phase III Multikine study

Oct. 24, 2012

Wilex reports data from phase III ARISER study

Oct. 18, 2012

Eli Lilly reports phase III data for ramucirumab in gastric cancer

Oct. 16, 2012

Oxford BioMedica provides update on TroVax development

Oct. 11, 2012

Genentech begins phase II trials of ADCs based on Seattle Genetics technology

Oct. 11, 2012

MedImmune enters immunotherapy collaboration with cancer organizations

Oct. 10, 2012

Dendritic cell vaccine compared to tumor cell vaccine in patients with metastatic melanoma

Oct. 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
Other news to note for July 20, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Cellution, Dimerix, Elutia, IPG, Jasper, Kira, Lumibird, Medtronic,...